Orbit Discovery Announces $7.6 Million Funding To Accelerate Growth In Peptide Discovery Business
Jul 20, 2021•almost 4 years ago
Amount Raised
$7.6 Million
Description
Orbit Discovery Ltd., (“Orbit”), a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, today announced that it has raised $7.6 million (USD) in funding.